CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 208 enrolled / 208 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05945563
NCT05945563N/ACompletedHigh Momentum (5.0/mo)Completion was 11mo ago
CompareCT.gov

Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

Methodist Health System·observational·Posted Jul 14, 2023·Updated Jun 11, 2026

In Brief

An observational study for Cerebral Aneurysm. Completed, enrolled 208 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

This registry study will investigate the incidence of and outcomes associated with clopidogrel hyper-responsive patients treated at Methodist Dallas Medical Center, beginning in January 2018, who suffered cerebral aneurysms.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Aneurysm
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 14, 2023
Enrollment StartJan 17, 2023
Primary CompletionJul 18, 2025
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 3.0 years ago